Cantor Fitzgerald Reiterates Neutral on CVS Health, Maintains $62 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on CVS Health and maintained a price target of $62.
August 19, 2024 | 3:22 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald has reiterated a Neutral rating for CVS Health, maintaining a price target of $62. This suggests that the analyst does not expect significant short-term price movement.
The reiteration of a Neutral rating and maintenance of the price target at $62 indicates that the analyst does not foresee significant changes in CVS Health's stock price in the short term. This suggests stability rather than volatility.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100